… plaque development. Unlike cancer, however, the researchers emphasize that atherosclerosis should … drivers could herald novel treatments aimed at halting or … University of Southern Denmark Keywords: Atherosclerosis, genetic alterations, clonal expansion, …

… a significant role in the development of atherosclerosis. For example, a cross … impact of medication use, particularly lipid-lowering and antihypertensive drugs, which … Additionally, collecting detailed data on medication use and other potential confounders …

… a high risk for atherosclerosis; however, its efficacy … Similar rates of treatment-emergent adverse events were … received funding from Novartis Pharma. Two authors reported … trial, and another author reported serving as a consultant for multiple pharmaceutical …

… , insulin resistance, type 2 diabetes, atherosclerosis, fatty liver disease, and asthma … aim of supporting the development of a treatment that could offer solutions … potentially bringing forward therapeutics to treat metabolic conditions that harm the …

… trial has come up with a groundbreaking daily pill, … continuing their existing cholesterol medications. Astonishing results emerged … the recent European Atherosclerosis Society Congress held … the best available treatments.”Professor Nicholls emphasized …

… medication, called Obicetrapib, underwent a Phase 3 clinical trial … existing cholesterol drugs.  A new daily pill could provide … month at the European Atherosclerosis Society Congress in the … funded by NewAmsterdam Pharma, a developer of Obicetrapib that …

… pathway and its relevance in treating a range of dermatologic … under investigation for challenging-to-treat diseases such as vitiligo, … of staying on the drug in order to sustain … in lipid-rich atherosclerosis after 1 year of treatment, reinforcing the …

… president of the European Atherosclerosis Society, director of the … dual receptor agonists in treating obesity and its various … more dual agonist treatments are being developed to target every … receptor agonists with other medications to expand the impact …

… medication could be more effective and easier to use than current treatments … study at the European Atherosclerosis Society Congress in Glasgow … much harder to treat and has been linked … by NewAmsterdam Pharma, the international BROADWAY trial is investigating …

… different exercise volumes on subclinical atherosclerosis, measured by CAC ( … computed tomography angiography). Subclinical atherosclerosis means that plaque formed by … measure cholesterol, treat with statins or multiple other medications, control blood …